Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
Won-Mook ChoiGi-Ae KimJonggi ChoiGwang Hyeon ChoiYun Bin LeeDong Hyun SinnYoung Suk LimPublished in: Gut (2023)
IU/mL, demonstrated the highest on-treatment HCC risk, despite long-term antiviral treatment. Early initiation of antiviral treatment, tailored to viral load, should be considered to minimise HCC risk in adult CHB patients without cirrhosis.